ProfileGDS4177 / 225081_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 87% 88% 93% 95% 54% 65% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated383.1687
GSM603099KU-812 non-treated446.0888
GSM603098KCL-22 Imatinib-treated731.2193
GSM603097KCL-22 non-treated1091.8695
GSM603102JURL-MK1 Imatinib-treated39.8454
GSM603101JURL-MK1 non-treated67.8765